Elevance Health, Inc.
ELV · Healthcare · · USDFahodi Score HOLD Long-term (Investment)
54
/ 100
Technical
75
Trend & RS
96
Momentum
58
Fundamental
56
Macro
24
Liquidity
40
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 96.0 | 10% |
| Momentum | 57.8 | 5% |
| Fundamental | 55.6 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 39.7 | 20% |
Trade Setup
| Entry | 423.18 |
| Stop Loss | 396.60 (6.3%) |
| Target 1 (1:1) | 449.76 (+6.3%) |
| Target 2 (2:1) | 476.34 (+12.6%) |
| ATR(14) | 13.29 (3.1%) |
| Risk per Share | 26.58 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 77.1 | +1.09 | |
| Momentum | 57.8 | +0.31 | |
| Quality | 31.9 | -0.72 | |
| Composite | 55.6 | ||
Quality Scores
Piotroski F-Score
5
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 18.1 | 22.0 | -18% below |
| P/B Ratio | 2.1 | 4.0 | Below |
| Dividend Yield | 1.6% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
290.72
vs
Market Price
427.33
Upside
-32.0%
| Margin of Safety | -47.0% |
| Stage 1 PV (5yr FCF) | 16,751,339,242 |
| Terminal Value PV | 46,060,204,279 |
| Total Enterprise Value | 62,811,543,521 |
Assumptions
| Base FCF | 4,070,492,716 |
| Growth Rate (5yr) | 2.0% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
35.15%
Full Kelly
17.58%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 54/100. Estimated win rate 56%, avg win 8.2%, avg loss 3.9%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
51.7
RSI(14)
3.7502
MACD
Relative Strength (RS) STRONG RS
89
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+11.8% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | -6.0% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
STRONG RS:
Top performer — outperforming the market and making new relative highs. Institutional accumulation likely.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 51.7 | NEUTRAL |
| Macd | 3.7502 | BEARISH |
| Ma Cross | 412.54 / 371.4 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.01x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 450.69 |
| Bollinger Upper | 445.12 |
| SMA(200) | 371.4 |
| SMA(50) | 412.54 |
| SMA(20) | 427.4 |
| Current Price | 427.33 |
| Bollinger Lower | 409.67 |
| 52-Week Low | 274.84 |
| ATR(14) | 13.29 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
Insufficient data for Wyckoff analysis.
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 1.52x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.64x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.21x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.48x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.01x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 427.72 | Above Kijun |
| Kijun-sen (26) | 415.67 | Base line |
| Senkou A | 421.69 | Leading span A |
| Senkou B | 413.22 | Leading span B |
| Cloud | 413.22 – 421.69 | Bullish (Green) |
| Price vs Cloud | 423.18 | Above Cloud |
| Chikou Span | 386.43 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
2 bars
Momentum:
BEARISH
BB: 409.67 – 445.12 | KC: 407.35 – 447.44
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 374.74
Anchor: 2026-03-09 (52w Low)
ABOVE AVWAP
+12.9%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/ELV
Valuation
| Metric | Value |
|---|---|
| Market Cap | 92.33B |
| P/E (TTM) | 18.15 |
| Forward P/E | N/A |
| P/B | 2.07 |
| EPS | 23.55 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 1.4% |
| Profit Margin | 2.5% |
| ROE | 11.5% |
| Debt/Equity | 68.66 |
| Current Ratio | 1.47 |
| Dividend Yield | 1.6% |
| Payout Ratio | N/A |
| Beta | 0.63 |
Trading Data
427.33
Open
427.33
Day High
427.33
Day Low
51.3K
Volume (0.0x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)